Cargando…
A novel tetrapeptide fluorescence sensor for early diagnosis of prostate cancer based on imaging Zn(2+) in healthy versus cancerous cells
Zinc as a biomarker can be used to diagnose the early stage prostate cancer, while ZIP1 protein, a zinc transporter is significantly down-regulated in prostate cancer cells. This behavior leads to the apparent alteration of the enrichment ability for zinc between early prostate cancer tissues and he...
Autores principales: | An, Yong, Chang, Wei, Wang, Wei, Wu, Hao, Pu, Ke, Wu, Anhu, Qin, Ze, Tao, Yan, Yue, Zhongjin, Wang, Peng, Wang, Zhiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256208/ https://www.ncbi.nlm.nih.gov/pubmed/32489681 http://dx.doi.org/10.1016/j.jare.2020.04.008 |
Ejemplares similares
-
Zn-dependent β-amyloid Aggregation and its Reversal by the Tetrapeptide HAEE
por: Mitkevich, Vladimir A, et al.
Publicado: (2023) -
Directed Discovery of Tetrapeptide Emulsifiers
por: Scott, Gary G., et al.
Publicado: (2022) -
Selective Dendritic Fluorescent Sensors for Zn(II)
por: Wang, Feng, et al.
Publicado: (2008) -
Diketopyrrolopyrrole-based fluorescence probes for the imaging of lysosomal Zn(2+) and identification of prostate cancer in human tissue
por: Du, Chenchen, et al.
Publicado: (2019) -
Anti-tumour effect of the physiological tetrapeptide, tuftsin.
por: Nishioka, K.
Publicado: (1979)